Instil Bio, Inc.TILNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank50
3Y CAGR-26.4%
5Y CAGR+18.7%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
-26.4%/yr
Annual compound
5Y CAGR
+18.7%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$79.74M+8.4%
2024$73.54M-53.8%
2023$159.17M-20.5%
2022$200.18M+28.7%
2021$155.56M+360.5%
2020$33.78M+413.0%
2019$6.58M-